Addex Therapeutics Ltd (ADXN)
NASDAQ: ADXN · Real-Time Price · USD
6.81
0.00 (0.00%)
May 15, 2026, 4:00 PM EDT - Market closed
Addex Therapeutics Market Cap
Addex Therapeutics has a market cap or net worth of $6.67 million as of May 15, 2026. Its market cap has decreased by -2.01% in one year.
Market Cap
6.67M
Enterprise Value
3.93M
1-Year Change
-2.01%
Ranking
Category
Stock Price
$6.81
Market Cap Chart
Since May 22, 2007, Addex Therapeutics's market cap has decreased from $323.99M to $6.67M, a decrease of -97.94%. That is a compound annual growth rate of -18.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 6.67M | -18.38% |
| Dec 30, 2025 | 8.17M | 31.74% |
| Dec 30, 2024 | 6.20M | -15.53% |
| Dec 29, 2023 | 7.34M | -34.64% |
| Dec 30, 2022 | 11.23M | -73.95% |
| Dec 30, 2021 | 43.12M | -28.43% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evogene | 8.11M |
| Can-Fite BioPharma | 7.57M |
| BioAtla | 7.24M |
| Xenetic Biosciences | 7.13M |
| Acurx Pharmaceuticals | 7.12M |
| Aptorum Group | 6.89M |
| Immuron | 6.60M |
| XTL Biopharmaceuticals | 6.52M |